# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-24-000078
Filing Date
2024-11-08
Accepted
2024-11-08 16:01:40
Documents
78
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lgnd-20240930.htm iXBRL | 10-Q | 1454447
2 | EX-10.2 | exhibit102-severanceagreem.htm | EX-10.2 | 54388
3 | EX-31.1 | lgnd_93024exhibit311.htm | EX-31.1 | 15161
4 | EX-31.2 | lgnd_93024exhibit312.htm | EX-31.2 | 15431
5 | EX-32.1 | lgnd_93024exhibit321.htm | EX-32.1 | 11172
11 |  | image_0a.jpg | GRAPHIC | 124
12 |  | lgnd-20240930_g1.jpg | GRAPHIC | 43732
| Complete submission text file | 0000886163-24-000078.txt |  | 9461981

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lgnd-20240930.xsd | EX-101.SCH | 65654
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lgnd-20240930_cal.xml | EX-101.CAL | 112338
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lgnd-20240930_def.xml | EX-101.DEF | 441256
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lgnd-20240930_lab.xml | EX-101.LAB | 879180
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lgnd-20240930_pre.xml | EX-101.PRE | 638315
80 | EXTRACTED XBRL INSTANCE DOCUMENT | lgnd-20240930_htm.xml | XML | 1277581

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 241440381
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)